| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $97.12 ▼ -1.06% | Yesterday | $98.60 ▲ +0.45% | Tomorrow's Nektar Therapeutics Common Stock (NKTR) setup is anchored to $98.16 and targets $97.12 (-1.06%). The near-term read is downside; watch $101.10 / $95.22 because daily realized volatility is about 5.47%. |
Tomorrow's Nektar Therapeutics Common Stock (NKTR) setup is anchored to $98.16 and targets $97.12 (-1.06%). The near-term read is downside; watch $101.10 / $95.22 because daily realized volatility is about 5.47%. | ||||
| Week | $94.92 ▼ -3.30% | Last Week | $99.52 ▲ +1.39% | The 7-day Nektar Therapeutics Common Stock model moves from $99.52 to $94.92 (-3.30%). It gives downside momentum context for this stock, so breaks around $101.10 / $95.22 matter more than a single tick. |
The 7-day Nektar Therapeutics Common Stock model moves from $99.52 to $94.92 (-3.30%). It gives downside momentum context for this stock, so breaks around $101.10 / $95.22 matter more than a single tick. | ||||
| Month | $91.26 ▼ -7.03% | Last Month | $101.06 ▲ +2.95% | The 1-month Nektar Therapeutics Common Stock target is $91.26 (-7.03%), compared with the live reference near $98.16. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Nektar Therapeutics Common Stock target is $91.26 (-7.03%), compared with the live reference near $98.16. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $85.78 ▼ -12.62% | Last Year | $103.36 ▲ +5.30% | The 1-year Nektar Therapeutics Common Stock scenario points to $85.78 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Nektar Therapeutics Common Stock scenario points to $85.78 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $72.92 ▼ -25.71% | 5 Years Ago | $108.76 ▲ +10.80% | The 5-year Nektar Therapeutics Common Stock view is $72.92 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Nektar Therapeutics Common Stock view is $72.92 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $98.16 | Mid |
| Daily Change | -2.18% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $98.16 | Daily Change | -2.18% |
| Market Cap | $2.82B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.